Effect of a large dose of Di (2-ethylhexyl) phthalate (DEHP) on hepatic peroxisome in cynomolgus monkeys (Macaca Fascicularis)

Journal of Toxicologic Pathology

Volumn 23, Issue 2, 2010, Pages 75-83

  Satake, Shigeru ^a,b,c   Nakamura, Chika ^a   Minamide, Yoshiyuki ^a   Kudo, Shinobu ^a   Maeda, Hiroshi ^a   Chihaya, Yutaka ^a   Kamimura, Yasuhiro ^a   Miyajima, Hiroaki ^a   Sasaki, Jun ^b   Goryo, Masanobu ^b,c   Okada, Osuke ^b,c  

^a SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

^b IWATE UNIVERSITY   (Japan)

^c GIFU UNIVERSITY   (Japan)

Author keywords

Cynomolgus monkey; Di (2 ethylhexyl) phthalate (DEHP); Hepatocyte; Mitochondria; Peroxisome

Indexed keywords

CARNITINE ACETYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; MITOCHONDRIAL ENZYME; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FATTY ACID OXIDATION; FEMALE; HEPATOMEGALY; LIVER BIOPSY; LIVER MITOCHONDRION; MALE; MONKEY; NONHUMAN; PEROXISOME; REVIEW; SEX DIFFERENCE;

EID: 77957050203     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.23.75     Document Type: Review

References (33)

1. Platt DS and Thorp JM. Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrate. Biochem Pharmacol. 15: 915-925. 1966.
2. Lake BG and Gray TJ. Species differences in hepatic peroxisome proliferation. Biochem Soc Trans. 13: 859-861. 1985.
3. Rodricks JV and Turnbull D. Interspecies differences in peroxisomes and peroxisome proliferation. Toxicol Ind Health. 3: 197-212. 1987.
4. Fahimi HD, Baumgart E, Beier K, Pill J, Hartig F, and Volkl A. Ultrastructural and biochemical aspects of peroxisome proliferation and biogenesis in different mammalian species. In: Peroxisomes: Biology and importance in toxicology and medicine. G Gibson and B Lake (eds). London, Washington: Taylor and Francis. 395-424. 1993.
5. Blane GF and Pinaroli F. Fenofibrate: Animal toxicology in relation to side-effects in man (author's transl). Nouv Presse Med. 22: 3737-3746. 1980.
6. Graham MJ, Wilson SA, Winham MA, Spencer AJ, Rees JA, Old SL, and Bonner FW. Lack of peroxisome proliferation in marmoset liver following treatment with ciprofibrate for 3 years. Fundam Appl Toxicol. 22: 58-64. 1994.
7. Reddy JK, Lalwani ND, Qureshi SA, Reddy MK, and Moehle CM. Induction of hepatic peroxisome proliferation in non-rodent species, including primates. Am J Pathol. 114: 171-183. 1984.
8. Hoivik DJ, Qualls CW Jr, Mirabile RC, Cariello NF, Kimbrough CL, Colton HM, Anderson SP, Santostefano MJ, Morgan RJ, Dahl RR, Brown AR, Zhao Z, Mudd PN Jr, Oliver WB Jr, Brown HR, and Miller RT. Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys. Carcinogenesis. 25: 1757-1769. 2004.
9. Short RD, Robinson EC, Lington AW, and Chin AE. Metabolic and peroxisome proliferation studies with di(2-ethylhexyl)phthalate in rats and monkeys. Toxicol Ind Health. 3: 185-195. 1987.
10. Lake BG, Gray TJ, Foster JR, Stubberfield CR, and Gangolli SD. Comparative studies on di-(2-ethylhexyl) phthalateinduced hepatic peroxisome proliferation in the rat and hamster. Toxicol Appl Pharmacol. 72: 46-60. 1984.
11. Kurata Y, Kidachi F, Yokoyama M, Toyota N, Tsuchitani M, and Katoh M. Subchroni c t o x i c i t y of di (2-ethylhexyl)phthalate in common marmosets: Lack of hepatic peroxisome proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia. Toxicol Sci. 42: 49-56. 1988.
12. Pugh G Jr, Isenberg JS, Kamendulis LM, Ackley DC, Clare LJ, Brown R, Lington AW, Smith JH, and Klaunig JE. Effects of di-isononyl phthalate, di-2-ethylhexyl phthalate, and clofibrate in cynomolgus monkeys. Toxicol Sci. 56: 181-188. 2000.
13. Satake S, Tanigawa Y, Maeda H, Kamimura Y, Chihaya Y, Miyajima H, Goryo M, and Okada K. Morphological changes of mitochondria in the hepatocytes induced by administration of a large amount of di (2-ethylhexyl) phthalate (DEHP) to cynomolgus monkeys (Macaca fascicularis). J Toxicol Pathol. 21: 73-75. 2008.
14. Inoue K and Nakagawa S. Lipid III neutral lipid, lipoprotein and serum lipid, lipid peroxide. In: Seibutsu Yakkagaku Jikken Koza 3, Ichikawa A (ed). Hirokawa Publishing Co. Tokyo, 100-112. 2002 (In Japanese).
15. Mitchell FE, Prince SC, Hinton RH, Grasso P, and Bridges JW. Time and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl) phthalate. Toxicol Appl Pharmacol. 81: 371-392. 1985.
16. Nair N and Kurup CK. Effect of administration of diethylhexyl phthalate on the function and turnover of rat hepatic mitochondria. Biochim Biophys Acta. 925: 332-340. 1987.
17. Watanabe T. Drugs and hepatic peroxisome proliferation. Drug Metab Pharmacokinet. 1: 179-189. 1986.
18. Svoboda DJ. Unusual responses of rat hepatic and renal peroxisomes to RMI 14, 514, a new hypolipidemic agent. J Cell Biol. 78: 810-822. 1978.
19. Yamoto T, Ohashi Y, Furukawa T, Teranishi M, Manabe S, and Makita T. Change of the sex-dependent response to clofibrate in F344 rat liver during postnatal development. Toxicol Lett. 85: 77-83. 1996.
20. Doull J, Cattley R, Elcombe C, Lake BG, Swenberg J, Wilkinson C, Williams G, and Gemert MV. A cancer risk assessment of di(2-ethylhexyl)phthalate: Application of the new U.S. EPA risk assessment guidelines. Regul Toxicol Pharmacol. 29: 327-357. 1999.
21. Roberts RA. Peroxisome proliferators: mechanisms of adverse effects in rodents and molecular basis for species differences. Arch Toxicol. 73: 413-418. 1999.
22. Holden PR and Tugwood JD. Peroxisome proliferatoractivated receptor alpha: role in rodent liver cancer and species differences. J Mol Endocrinol. 22: 1-8. 1999.
23. Roberts RA, James NH, Hasmall SC, Holden PR, Lambe K, Macdonald N, West D, Woodyatt NJ, and Whitcome D. Apoptosis and pro l i feration in non-genotoxic carcinogenesis: species differences and role of PPARalpha. Toxicol Lett. 89: 112-113: 49-57. 2000.
24. Cariello NF, Romach EH, Colton HM, Ni H, Yoon L, Falls JG, Casey W, Creech D, Anderson SP, Benavides GR, Hoivik DJ, Brown R, and Miller RT. Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver. Toxicol Sci. 88: 250-264. 2005.
25. Ito Y, Yamanoshita O, Kurata Y, Kamijima M, Aoyama T, and Nakajima T. Induction of peroxisome proliferatoractivated receptor alpha (PPARalpha)-related enzymes by di(2-ethylhexyl) phthalate (DEHP) treatment in mice and rats, but not marmosets. Arch Toxicol. 81: 219-226. 2007.
26. Jeffrey M, Connie C, and Frank JG. Peroxisome proliferatoractivated receptor-α and liver cancer: where do we stand? J Mol Med. 83: 774-785. 2005.
27. Williams DF, de Jong W, Thomsen M, Farre ER, Gatti AM, Paunio MK, Petersen AH, and Marquardt H. Opinion on medical devices containing DEHP plasticised PVC; Neonates and other groups possibly at risk from DEHP toxicity. http://www.hosmat.eu/toxicovigilance/PvcDehp.pdf. 2002.
28. Rusyn I, Peters JM, and Cunningham ML. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit Rev Toxicol. 36: 459-479. 2006.
29. Peck CC, Odom DG, Friedman HI, Albro PW, Hass JR, Brady JT, and Jess DA. Di-2-ethylhexyl phthalate (DEHP) and mono-2-ethylhexyl phthalate (MEHP) accumulation in whole blood and red cell concentrates. Transfusion. 19: 137-146. 2003.
30. Woodyatt NJ, Lambe KG, Myers KA, Tugwood JD, and Roberts RA. The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: Significance for species differences in response to PPs. Carcinogenesis. 20: 369-372. 1999.
31. Lawrence JW, Li Y, Chen S, DeLuca JG, Berger JP, Umbenhauer DR, Moller DE, and Zhou G. Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) α. J Biol Chem. 276: 31521-31527. 2001.
32. Ganning AE, Brunk U, and Dallner G. Phthalate esters and their effect on the liver. Hepatology. 4: 541-547. 1984.
33. Ganning AE, Brunk U, Edlund C, Elhammer A, and Dallner G. Effects of prolonged administration of phthalate ester on the liver. Environ Health Perspect. 73: 251-258. 1987.